New oxygen sensor tested for kids of all skin tones

NCT ID NCT07223177

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study checks if a new oxygen monitoring technology (Philips FAST SpO2) works well with Masimo sensors in children under 22 years old, including newborns. Researchers will compare its accuracy to an already-approved device and see how well the sensor fits. The goal is to ensure reliable readings across different skin colors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could improve oxygen monitoring accuracy for babies and children in hospitals, especially across different skin pigmentations.

What could go wrong

This is a small, early-stage device verification study, not a treatment trial. It may not lead to any clinical changes or product improvements.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPO2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Paradigm Clinical Research

    RECRUITING

    Modesto, California, 95355, United States

    Contact Phone: •••-•••-••••

  • Paradigm Clinical Research

    RECRUITING

    San Diego, California, 92108, United States

    Contact Phone: •••-•••-••••